- Home
- MSA vs FBIOP Comparison
MSA vs FBIOP Comparison
Compare MSA & FBIOP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MSA
- FBIOP
- Stock Information
- Founded
- MSA 1914
- FBIOP N/A
- Country
- MSA United States
- FBIOP United States
- Employees
- MSA N/A
- FBIOP 101
- Industry
- MSA Industrial Specialties
- FBIOP Biotechnology: Pharmaceutical Preparations
- Sector
- MSA Health Care
- FBIOP Health Care
- Exchange
- MSA Nasdaq
- FBIOP Nasdaq
- Market Cap
- MSA N/A
- FBIOP N/A
- IPO Year
- MSA N/A
- FBIOP N/A
- Fundamental
- Price
- MSA $161.84
- FBIOP $7.87
- Analyst Decision
- MSA Strong Buy
- FBIOP
- Analyst Count
- MSA 5
- FBIOP 0
- Target Price
- MSA $190.80
- FBIOP N/A
- AVG Volume (30 Days)
- MSA 229.5K
- FBIOP N/A
- Earning Date
- MSA 07-23-2025
- FBIOP N/A
- Dividend Yield
- MSA 1.31%
- FBIOP N/A
- EPS Growth
- MSA 7.50
- FBIOP N/A
- EPS
- MSA 7.25
- FBIOP N/A
- Revenue
- MSA $1,816,178,000.00
- FBIOP N/A
- Revenue This Year
- MSA $2.92
- FBIOP N/A
- Revenue Next Year
- MSA $5.27
- FBIOP N/A
- P/E Ratio
- MSA $22.32
- FBIOP N/A
- Revenue Growth
- MSA 0.75
- FBIOP N/A
- 52 Week Low
- MSA $127.86
- FBIOP N/A
- 52 Week High
- MSA $200.61
- FBIOP N/A
- Technical
- Relative Strength Index (RSI)
- MSA 60.52
- FBIOP 73.92
- Support Level
- MSA $156.12
- FBIOP $6.43
- Resistance Level
- MSA $164.68
- FBIOP $7.00
- Average True Range (ATR)
- MSA 2.17
- FBIOP 0.37
- MACD
- MSA 0.07
- FBIOP 0.12
- Stochastic Oscillator
- MSA 66.82
- FBIOP 94.75
About FBIOP Fortress Biotech Inc.
Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology and therapeutics sectors.